SDMH EQAS
External Quality Assessment Scheme
| Month: | Year: 2026 | Cycle No.: |
|---|---|---|
| Opening Date: | Closing Date: |
General Instructions
Intended Use:
This programme involves the testing of biological samples provided as part of the External Quality Assessment Scheme (EQAS). Although certain infection statuses of the samples may be known pertaining to the samples, all materials, the materials cannot be labeled as non infectious. Participants are advised to follow universal precautions during handling, storage, and testing, as with routine blood samples. The EQAS programme is intended to assess the performance of Blood Centers as per their routine practice.
Instructions for performing tests:
• EQAS samples must be tested in the same manner as routine donor or patient samples, following the standard testing strategy and protocols practiced in the laboratory.
| S.No. | Sample No. | Tests | Type of Samples | Preservative | Instructions for use |
|---|---|---|---|---|---|
| A. | 01 to 05 | HBsAg | Serum | 0.1%Sodium Azide | Centrifuge Samples |
| Anti-HIV1 &2 | |||||
| Anti-HCV | |||||
| Syphilis | |||||
| B. | 06 & 07 | Malaria Parasite | Whole Blood | CPDA-1with Preservative | Ready to use mix well before use Note: Light Pink Colour in the Sample is due to CPDA-1 preservative, Not due to hemolysis |
| Hemoglobin | |||||
| C. | 08 | Direct AntiglobulinTest | 5% Red Cells Suspension | Celpresol | Ready to use mix well before use |
| D. | 08to11 | ABO Rh (D) | 5% RedCells Suspension & Plasma | Celpresol | Ready to use mix well before use (5% Red cells Suspension) & centrifuge plasma before use Note: Light Pink Colour in the Sample is due to CPDA-1 preservative, Not due to hemolysis |
| E. | 12to14 | Cross-match with Samples No. 09 to11 | Plasma | - | Ready to use Centrifuge plasma before use |
| F. | 15 | Antibody Screening and Identification | Plasma | 0.1%Sodium Azide | Ready to use Centrifuge plasma before use |
| G. | 16 | NAT Test (Nucleic Acid Amplification Test) | Plasma | - | Ready to use Centrifuge plasma before use |
Abbreviations Used:
IAHG-Indirect AntiHuman Globulin, LISS-Low Ionic Strength Saline
Instructions for Storage &Testing of EQAS Samples
1. Process the EQAS samples alongside routine donor or patient specimens, using the same methodology, equipment, reagents, and technical staff as employed in routine laboratory practice.
2. Store all samples at 2–8°C for the duration of the testing period.
3. Samples MUST be processed immediately due to short shelf life of red cells.
Note: All EQAS samples are potentially infectious and must be handled in accordance with Biosafety precautions.
EQAS samples must be tested in the same manner as routine donor or patient samples, following the standard testing strategy and protocols practiced in the Blood Centre.
Instructions for Returning the Results
1. Retain the original result entry form and submit results via the designated reporting system
2. Results submitted in any format other than the prescribed one will not be considered for evaluation.
3. Results received after the specified closing date will not be included in the analysis.
4. Maintain all records for audit and verification.
For any queries: email or contact:
Email- eqas@sdmh.in
Phone No- +91-7982732346